This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Toyobo Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jun Okamoto - Innovator in Hemoglobin Measurement Technology.
Introduction
Jun Okamoto is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of hemoglobin A1c levels. His innovative work has led to the development of a patented measurement sample diluent that enhances the accuracy and sensitivity of HbA1c testing.
Latest Patents
Jun Okamoto holds a patent for a "Measurement sample dilution liquid, kit, and measurement method." This invention provides a measurement sample diluent that enables the precise measurement of the proportion of HbA1c in total Hb molecules. The diluent is designed to ensure high sensitivity, accuracy, and correlation with HPLC, while minimizing the impact of mixing time on the measurement process. The diluent is an aqueous solution containing a non-ionic surfactant, an anionic surfactant, and a buffer, making it a valuable tool for immunochromatography in quantifying hemoglobin A1c levels.
Career Highlights
Jun Okamoto is associated with Toyobo Co., Ltd., a company known for its advancements in various fields, including biotechnology and materials science. His work at Toyobo has allowed him to focus on developing innovative solutions for medical diagnostics.
Collaborations
Jun Okamoto has collaborated with notable colleagues, including Keizo Yoneda and Hiroyuki Wakui. These collaborations have contributed to the advancement of research and development in the field of hemoglobin measurement.
Conclusion
Jun Okamoto's contributions to the field of medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare technology. His work continues to impact the accuracy of hemoglobin A1c testing, benefiting both healthcare professionals and patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
